UXI4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cyclacel Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.257 EUR Market Closed

Market Cap: €2.7m

C	Cyclacel Pharmaceuticals Inc F:UXI4	US
W	Westamerica Corp OTC:WACC	US
R	Russel Metals Inc F:RMZ	CA
	Kanamic Network Co Ltd F:0WT	JP
W	Wolverine Technologies Corp OTC:WOLV	CA
	Orpea SA F:OPA0	FR
	Compagnie du Bois Sauvage SA F:C5S	BE
	Nicola Mining Inc F:HLIA	CA
S	Silk Road Medical Inc F:2OW	US
	Oceanic Iron Ore Corp XTSX:FEO	CA
	Mersen SA PAR:MRN	FR
	Nippon Kinzoku Co Ltd TSE:5491	JP

Profitability Summary

Cyclacel Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-103 580%

Negative 3Y Average Operating Margin

-35 869%

Declining Operating Margin

-7 722% > -103 580%

Negative Net Margin

-64 280%

Negative 3Y Average Net Margin

-25 815%

Declining Net Margin

-6 478% > -64 280%

Negative Free Cash Flow Margin

-87 260%

Negative 3Y Average Free Cash Flow Margin

-27 726%

Declining Free Cash Flow Margin

-5 492% > -87 260%

Negative ROE

-278%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-98%

ROIC is Increasing

-588% > 925%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.